At 15 years of follow-up, metabolic surgery “was not only safe” but also significantly reduced major adverse liver outcomes and decompensation in patients with metabolic dysfunction-associated steatohepatitis and compensated cirrhosis.“Previous studies suggested excellent clinical outcomes in patients with MASH and fibrosis stages 1 to 3 with improvement in both cardiac and
Survodutide upholds promising reduced liver fat, fibrosis biomarkers in MASH at 28 weeks
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Naim Alkhouri, MD: Interim Analysis of Phase 2 Survodutide Data Show Promise for MASH, Fibrosis
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.
Free Hepatitis C screening Saturday at Flagstaff Family Food Center
azdailysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from azdailysun.com Daily Mail and Mail on Sunday newspapers.